Results 111 to 120 of about 34,707 (260)

The Potential of Bisphosphonate Risedronate Hydrogel in Preventing Relapse Movement

, 2022
Objectives: To analyze the effect of risedronate hydrogel on enzyme alkaline phosphatase (ALP) and osteoclast/osteoblast ratio during tooth relapse movement Materials and methods: The research design is experimental with time series.
Utari, Tita Ratya, Ana, Ika Dewi, Asmara, Widya, Pudyani, Pinandi Sri   +3 more
core  

Mandibular Overdentures on Four Immediately Loaded Mini‐Implants Versus Two‐Delayed Loaded Regular Implants: 1‐Year, Two‐Center RCT on Patient‐Reported Outcomes

Clinical Oral Implants Research, EarlyView.
ABSTRACT Objective This one‐year randomized clinical trial compared the effects of mandibular implant‐overdentures (IODs) on two two‐piece regular‐neck tissue‐level implants (Group A) or on four mini‐implants (Group B) with different loading protocols in edentulous patients concerning dental Patient‐Reported Outcomes (dPROs).
Martin Schimmel, Cláudio Rodrigues Leles, Nicole Schenk, Simone F. M. Janner, Beat Wallkamm, Valérie G. A. Suter, Samir Abou‐Ayash, Clemens Raabe   +7 more
wiley   +1 more source

Spectrum of activity and mechanisms of azole–bisphosphonate synergy in pathogenic Candida

Microbiology Spectrum
Candidiasis places a significant burden on human health and can range from common superficial vulvovaginal and oral infections to invasive diseases with high mortality.
Aidan Kane, Hue Dinh, Leona Campbell, Amy K. Cain, David Hibbs, Dee Carter   +5 more
doaj   +1 more source

BISPHOSPHONATE IN DENTİSTRY

  Bisphosphonates are widely used in a variety of conditions, particularly in postmenopausal women to prevent age-related osteoporosis and associated fractures.
Gunduz, Alpaslan
core   +1 more source

Prosthodontic care and management of patients with MRONJ from different microbiological backgrounds

Fogorvosi Szemle
Medication-related osteonecrosis of the Jaw (MRONJ) is a severe condition of multifactorial origin, with its exact etiological factors still not fully understood.
Flóra Alíz Lakatos, László Kádár, Péter Schmidt, János König, Andrea Bródy, Károly Frigyes Mensch   +5 more
doaj   +1 more source

Musculoskeletal health among adults with cerebral palsy: A systematic review

Developmental Medicine &Child Neurology, EarlyView.
Abstract Aim To describe the burden of, and investigate prognostic factors for, osteoarthritis, osteopenia and/or osteoporosis, spondylosis, and fracture, and to investigate the effectiveness of protocols for monitoring musculoskeletal disorders and interventions for managing osteoarthritis in adults with cerebral palsy (CP).
Jennifer M. Ryan, Jessica Burke, Rachel Byrne, Emily Capellari, Christina M Marciniak, Maram Sofiany, Reuel Jalal, Mark Peterson, The Adult CP Clinical Practice Guideline Working Group, Jan Willem Gorter, Ashley Harris Whaley, Christine Imms   +11 more
wiley   +1 more source

Adherence to bisphosphonate treatment by elderly women

, 2008
OBJECTIVE: The aim of this study was to evaluate the relationship between adherence to bisphosphonate treatment by postmenopausal women and demographic, health, and lifestyle factors before treatment in a country with universal subsidies for ...
Dobson, Annette, Hockey, Richard, Berecki-Gisolf, Janneke   +2 more
core   +1 more source

Potential indications for initiating bisphosphonate treatment.

, 2015
Potential indications for initiating bisphosphonate treatment.
Jing Xie (180526), Seoyoung C. Kim (685406), Angela Tong (685405)   +2 more
core   +1 more source

Type 2 Diabetes Is Associated With Increased Complications and Mortality After Hip Fracture in Older Adults Aged 60 Years or Older

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Type 2 diabetes (T2D) is associated with increased hip fracture risk. We evaluated the impact of T2D on post‐hip fracture outcomes, which is less well described. Materials and Methods Individuals aged ≥ 60 years hospitalised for hip fractures between 2011 and 2020 were identified from the territory‐wide electronic health records of Hong ...
Xincheng Zou, Manju Chandran, Xi Xiong, Chi‐Ho Lee, Wing‐Sun Chow, Carol H. Y. Fong, Lawrence C. M. Lau, Ka‐Shing Cheung, Carlos K. H. Wong, Kathryn C. B. Tan, Yu‐Cho Woo, Karen S. L. Lam, David T. W. Lui   +12 more
wiley   +1 more source

Glucagon‐Like Peptide‐1 Receptor Agonists and Incident Major Adverse Liver Outcomes in People With Type 2 Diabetes and Metabolic Dysfunction‐Associated Steatotic Liver Disease

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Treatment options for metabolic dysfunction‐associated steatotic liver disease (MASLD) are limited. While glucagon‐like peptide‐1 receptor agonists (GLP‐1 RA) and sodium‐glucose cotransporter‐2 (SGLT‐2) inhibitors improve cardiovascular outcomes, comparative effectiveness on liver‐related outcomes remains unclear.
Gregor A. Maier, Ramon A. Hofmann, Michael Roden, Wolfgang Rathmann, Oliver Kuss   +4 more
wiley   +1 more source